Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

by Global Biodefense Staff
May 10, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network

Spc. Matthew Shlaimon, 1-158th Infantry Battalion, conducts training for medical personnel at a local Tempe, Ariz. nursing home who will soon facilitate a COVID-19 point-of-care testing system to nursing home residents, visitors and employees. Credit: Michael Matkin

Expanded funding will support activieitechnology development and clinical testing of prototype point-of-care systems.

The National Institute for Biomedical Imaging and Bioengineering, part of the National Institutes of Health (NIH), has announced intentions to reissue PAR-17-453, Point-of-Care Technologies Research Network (POCTRN), with additional partnering NIH Institutes and Centers.

The purpose of this funding opportunity announcement is to solicit Technology Research and Development Center (TRDC) applications for the POCTRN. POCTRN’s purpose is to drive the development and application of innovative point of care, home-based, improved clinical laboratory tests and testing technologies.

The POCTRN TRDCs will merge scientific and technological capabilities with clinical need to address unmet testing, monitoring, and treatment areas.

The network of POCTRN TRDCs will have broad expertise across many research areas and will cover multiple levels of technology readiness from proof of feasibility through products and procedures used in clinical practice.

Credit: Michael Matkin

The scope of work covered within each Center will include, but are not limited to:

  • Sub-project awards to support point-of-care technology development activities led by investigators
  • Assessment and communication of unmet clinical needs in point-of-care testing
  • Collaborations with physical scientists, computational scientists, and engineers (as well as researchers from other relevant disciplines, as appropriate) on technology development projects
  • Development of external partnerships (e.g., technology, clinical, industry, and regulatory) necessary to move enabling technologies toward clinical applications
  • Validation and clinical testing of prototype point-of-care devices
  • Creation of training opportunities for technology developers and other stakeholders on clinical issues related to the development of point-of-care devices.

The Funding Opportunity Announcement is expected to be published in June 2022 with an application due date in Fall 2022. This opportunity is open to all applicants, including the existing POCTRN grantees as well as new applicants.

Notice of Intent to Publish a Funding Opportunity Announcement for Point-of-Care Technologies Research Network Centers (U54 Clinical Trial Optional). National Institute of Biomedical Imaging and Bioengineering (NIBIB), Notice Number: NOT-EB-22-001. First Estimated Application Due Date: September 26, 2022.

Tags: COVID-19Editor PickOpportunitiesPOC Diagnostics

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC